Early laboratory results in mice show the drug PXS-5505 increases survival when combined with chemotherapy in the treatment of an aggressive form of pancreatic cancer.
Tackling the scar tissue that shields pancreatic tumours from effective drug access is a promising advance in a notoriously hard-to-treat cancer.
UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the program, thanks to a $3.75 million grant from the Cancer Institute NSW.
UNSW scientists have grown human pancreatic cancer tumours in the lab – their model is the first of its kind, with important future clinical implications.
Four UNSW Sydney researchers have received funding for pioneering work into pancreatic, breast and bone cancers.
This World Pancreatic Cancer Day, we’re highlighting some of the many UNSW Sydney researchers working to improve patient outcomes.
Nanomedicine presentation earns PhD candidate John Kokkinos top prize at UNSW 3MT grand final.
Pancreatic and brain cancer researcher Dr Angelica Merlot has been nominated for 2019 NSW Young Woman of the Year.
UNSW Medicine’s Professor Minoti Apte, OAM has received the Gastroenterological Society of Australia (GESA) Distinguished Researcher Prize 2018.
The Avner Pancreatic Cancer Foundation, Australia’s peak body for the disease, has awarded a second grant to UNSW's Professor Minoti Apte.